tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daina Graybosch, 85 are a BUY (80.19%), 21 are a HOLD (19.81%).
Analyst Daina Graybosch, currently employed at LEERINK, carries an average stock price target met ratio of 49.56% that have a potential upside of 29.87% achieved within 268 days.
Daina Graybosch’s has documented 174 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ITOS, Iteos Therapeutics at 14-May-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS ) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$133
$47.93 (56.34%)
$82
2 months 9 days ago
(31-Jul-2025)
2/3 (66.67%)
$61.61 (86.30%)
126
Buy
$115
$29.93 (35.18%)
$115
3 months 24 days ago
(16-Jun-2025)
9/11 (81.82%)
$50.91 (79.44%)
104
Buy
$105
$19.93 (23.43%)
$105
10 months ago
(10-Dec-2024)
17/18 (94.44%)
$22.73 (27.63%)
81
Buy
$114
$28.93 (34.01%)
$77
10 months ago
(10-Dec-2024)
2/3 (66.67%)
$31.73 (38.57%)
33
Buy
$112
$26.93 (31.66%)
$100
10 months 1 days ago
(09-Dec-2024)
4/5 (80%)
$29.05 (35.02%)
106
Which stock is Daina Graybosch is most bullish on?
Which stock is Daina Graybosch is most reserved on?
What Year was the first public recommendation made by Daina Graybosch?
